Back to results
US 10,351,577 B2Granted
Ether analogues of galiellalactone
AssigneeGlactone Pharma Development AB
InventorsJohansson Martin, Olov Sterner, Anders Bjartell, Rebecka Hellsten, Zilma Escobar
Life of this patent
Estimating the term…
Abstract
Ether analogues of galiellalactone, methods of preparing the analogues, and use of the analogues in the treatment of cancer are disclosed. The analogues are of formula (I) or (II):
Claims9
A compound according to formula (I)
- wherein
- R1 and R1′ are independently selected from the group consisting of H, C1-5 alkyl, C1-5 fluoroalkyl, halo, cyano, nitro, —OH, OC1-5 alkyl, C1-5 alkyleneOH, C1-5 alkyleneOC1-5 alkyl, C3-8 non-aromatic carbocycle, OC1-5 fluoroalkyl, C1-3 alkyleneOC1-5 fluoroalkyl, OC(O)C1-5 alkyl, C1-3 alkyleneOC(O)C1-5 alkyl, OC2-3 alkyleneNH2, OC2-3 alkyleneNH(C1-5 alkyl), OC2-3 alkyleneN(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, —NH2, —NH(C1-5 alkyl), C1-3 alkyleneNH2, C1-3 alkyleneNH(C1-5 alkyl), —N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C1-3 alkyleneN(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, NHC(O)C1-5 alkyl, N(C1-5 alkyl)C(O)C1-5 alkyl, C1-3 alkyleneNHC(O)C1-5 alkyl, C1-3 alkyleneN(C1-5 alkyl)C(O)C1-5 alkyl,
- NHaryl, C1-3 alkyleneNHaryl, wherein the aryl is unsubstituted or substituted with one or more substituents independently selected from the group consisting of C1-5 alkyl, C1-5 fluoroalkyl, halo, —OH, OC1-5 alkyl, C1-5 alkyleneOH, C1-5 alkyleneOC1-5 alkyl, nitro, cyano, NH2, NH(C1-5 alkyl), and N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different,
- aryl, C1-3 alkylene-aryl, wherein the aryl is unsubstituted or substituted with one or several substituents independently selected from the group consisting of C1-5 alkyl, C1-5 fluoroalkyl, halo, —OH, OC1-5 alkyl, C1-5 alkyleneOH, C1-5 alkyleneOC1-5 alkyl, nitro, cyano, —NH2, —NH(C1-5 alkyl), and N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different,
- —SH, —SC1-5 alkyl, C1-5 alkylene-SH, C1-5 alkylene-SC1-5 alkyl, SC1-5 fluoroalkyl, C1-5 alkyleneSC1-5 fluoroalkyl, SO2C1-5 alkyl, C1-5 alkylene-SO2C1-5 alkyl, SO2C1-5 fluoroalkyl, C1-5 alkylene-SO2C1-5 fluoroalkyl, SO2NH2, SO2NH(C1-5 alkyl), SO2N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C1-5 alkyleneSO2NH2, C1-5 alkyleneSO2NH(C1-5 alkyl), C1-5 alkyleneSO2N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different,
- SO2NHaryl, C1-5 alkyleneSO2NHaryl, wherein the aryl is unsubstituted or substituted with a one or several substituents independently selected from the group consisting of C1-5 alkyl, C1-5 fluoroalkyl, halo, —OH, OC1-5 alkyl, C1-5 alkyleneOH, C1-5 alkyleneOC1-5 alkyl, nitro, cyano, —NH2, —NH(C1-5 alkyl), and N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different,
- SO2N(C1-5 alkyl)aryl, and C1-5 alkyleneSO2N(C1-5 alkyl)aryl, wherein the aryl is unsubstituted or substituted with a one or several substituents independently selected from the group consisting of C1-5 alkyl, C1-5 fluoroalkyl, halo, —OH, OC1-5 alkyl, C1-5 alkyleneOH, C1-5 alkyleneOC1-5 alkyl, nitro, cyano, —NH2, —NH(C1-5 alkyl), and N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different;
- R2, R2′, R3, and R3′ are each independently selected from the group consisting of H, halo, —OH, C1-5 alkyl, and C1-5 fluoroalkyl;
- R4 and R4′ are independently selected from the group consisting of H, C1-5 alkyl, aryl, and CH2aryl;
- A is selected from the group consisting of a bond, C1-5 alkylene or NR10;
- R10 is H or C1-C3 alkyl;
- Cy1 is pyridinyl;
- R5 is independently selected from the group consisting of C1-8 alkyl, C1-5 haloalkyl, halo, cyano, —CH2-cyano, —OH, OC1-5 alkyl, C1-8 alkyleneOC1-5 alkyl, O-aryl, C1-8 alkylene-O-aryl, —SH, SC1-5 alkyl, SO2H, SO2C1-5 alkyl, C1-3 alkyleneSO2H, C1-3 alkyleneSO2C1-5 alkyl, OC1-3 fluroroalkyl, C1-3 alkyleneOC1-3 fluroroalkyl, NH2, NH(C1-3 alkyl), C1-3 alkylene-NH2, C1-3 alkyleneNH(C1-3 alkyl), N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C1-3 alkyleneN(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C(O)OH, C(O)OC1-5 alkyl, C1-3 alkyleneC(O)OH, C1-3 alkyleneC(O)OC1-5 alkyl, OC(O)H, OC(O)C1-5 alkyl, C1-3 alkyleneOC(O)H, C1-3 alkyleneOC(O)C1-5 alkyl, NHC(O)H, NHC(O)C1-5 alkyl, N(C1-3 alkyl)C(O)H, N(C1-3 alkyl)C(O)C1-5 alkyl, C1-3 alkyleneNHC(O)H, C1-3 alkyleneNHC(O)C1-5 alkyl, C1-3 alkyleneN(C1-3 alkyl)C(O)H, C1-3 alkyleneN(C1-3 alkyl)C(O)C1-5 alkyl, C(O)NH2, C(O)NH(C1-3 alkyl), C1-3 alkyleneC(O)NH2, C1-3 alkyleneC(O)NH(C1-3 alkyl), C(O)N(C1-5 alkyl)2, in which the C1-5 alkyl are the same or different, C1-3 alkyleneC(O)N(C1-5 alkyl)2, in which the C1-5 alkyl are the same or different, nitro, C(O)H, C(O)C1-C5 alkyl, NHSO2C1-C3 alkyl, N(C1-C3 alkyl)SO2C1-C3 alkyl, NHSO2C1-C3 fluoroalkyl, N(C1-C3 alkyl)SO2C1-C3 fluoroalkyl, OC2-C3alkyleneNH2, OC2-C3alkyleneNH(C1-C3 alkyl), OC2-C3alkyleneN(C1-C3 alkyl)2 in which the C1-3 alkyl are the same or different, and
- wherein
- D is selected from the group consisting of a bond, C1-3 alkylene, O—C1-3 alkylene, C1-3 alkylene-O—C1-3 alkylene, OC(O)C1-3 alkylene, C1-3 alkylene-OC(O)-C1-3 alkylene, C(O)OC1-3 alkylene, C1-3 alkylene-C(O)O—C1-3 alkylene, C(O)N(H)(C1-3 alkylene), C(O)N(C1-3 alkyl)(C1-3 alkylene), C1-3 alkylene-C(O)N(H)(C1-3 alkylene), C1-3 alkylene-C(O)N(C1-3 alkyl)(C1-3 alkylene), N(H)C(O)C1-3 alkylene, N(C1-3 alkyl)C(O)C1-3 alkylene, C1-3 alkylene-N(H)C(O)C1-3 alkylene, C1-3 alkylene-N(C1-3 alkyl)C(O)C1-3 alkylene, —NHSO2-, —SO2NH—, SO2, SO, C(O), C1-3 alkylene-C(O), C(O)C1-3 alkylene, C1-3 alkylene C(O)C1-3 alkylene, NH, N(C1-3 alkyl), NH-C1-3 alkylene, N(C1-3 alkyl)-C1-3 alkylene, C1-3 alkylene-NH, C1-3 alkylene-N(C1-3 alkyl), C1-3 alkylene-NH-C1-3 alkylene, C1-3 alkylene-N(C1-3 alkyl)-C1-3 alkylene, and S;
- Cy2 is a phenyl, or a C3-8 non-aromatic carbocycle;
- m is an integer selected from the group consisting of 0, 1, 2, 3, 4, and 5;
- R6 is independently selected from oxo, C1-5 alkyl, C1-5 fluoroalkyl, halo, cyano, —CH2-cyano, —OH, OC1-5 alkyl, C1-5 alkylene-OH, C1-5 alkyleneOC1-5 alkyl, —SH, SC1-5 alkyl, SO2H, SO2C1-5 alkyl, C1-3 alkyleneSO2H, C1-3 alkyleneSO2C1-5 alkyl, OC1-3 fluoroalkyl, C1-3 alkyleneOC1-3 fluoroalkyl, NH2, NH(C1-3 alkyl), C1-3 alkylene-NH2, C1-3 alkylene-NH(C1-3 alkyl), N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C1-3 alkyleneN(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C(O)OH, C(O)OC1-5 alkyl, C1-3 alkylene-C(O)OH, C1-3 alkylene-C(O)OC1-5 alkyl, OC(O)H, OC(O)C1-5 alkyl, C1-3 alkylene-OC(O)H, C1-3 alkylene-OC(O)C1-5 alkyl, NHC(O)H, NHC(O)C1-3 alkyl, N(C1-3 alkyl)C(O)H, N(C1-3 alkyl)C(O)C1-3 alkyl, C1-3 alkylene-NHC(O)H, C1-3 alkylene-NHC(O)C1-3 alkyl, C1-3 alkylene-N(C1-3 alkyl)C(O)H, C1-3 alkylene-N(C1-3 alkyl)C(O)C1-3 alkyl, C(O)NH2, C(O)NH(C1-3 alkyl), C1-3 alkylene-C(O)NH2, C1-3 alkylene-C(O)NH(C1-3 alkyl), C(O)N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C1-3 alkyleneC(O)N(C1-5 alkyl)2 in which the C1-5 alkyl are the same or different, C(O)N(C4-5 alkylene), C1-3 alkyleneC(O)N(C4-5 alkylene), nitro, C(O)H, C(O)C1-C5 alkyl, C(O)C1-C3 fluoroalkyl, NHSO2C1-C3 alkyl, N(C1-C3 alkyl)SO2C1-C3 alkyl, NHSO2C1-C3 fluoroalkyl, N(C1-C3 alkyl)SO2C1-C3 fluoroalkyl, OC2-C3alkyleneNH2, OC2-C3alkyleneNH(C1-C3 alkyl), and OC2-C3alkyleneN(C1-C3 alkyl)2 in which the C1-3 alkyl are the same or different;
- or
- when two R6 are present, each R6 is combined to form a fused ring or spiro ring with Cy2;
- n is an integer selected from the group consisting of 0, 1, and 2;
- as a free base, an acid in its non-charged protonated form, a pharmaceutically acceptable addition salt, a pure diastereomer, a pure enantiomer, a diastereomeric mixture, a racemic mixture, a scalemic mixture, a corresponding tautomeric form resulting from a hydrogen shift between two hetero-atoms and/or the corresponding tautomeric form resulting from a keto-enol tautomerization.
19 more elements
Dependencies are inferred from the claim text.